Cart
sales@molnova.com
XYLOBIOSE
CAS No. 6860-47-5
XYLOBIOSE( —— )
Catalog No. M20482 CAS No. 6860-47-5
XYLOBIOSE ia a natural productand exhibited therapeutic potential for treating obesity which involved suppression of fat deposition and obesity-related metabolic disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 69 | In Stock |
|
| 10MG | 97 | In Stock |
|
| 25MG | 161 | In Stock |
|
| 50MG | 239 | In Stock |
|
| 100MG | 356 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXYLOBIOSE
-
NoteResearch use only, not for human use.
-
Brief DescriptionXYLOBIOSE ia a natural productand exhibited therapeutic potential for treating obesity which involved suppression of fat deposition and obesity-related metabolic disorders.
-
DescriptionXYLOBIOSE ia a natural productand exhibited therapeutic potential for treating obesity which involved suppression of fat deposition and obesity-related metabolic disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetTNF
-
RecptorTNF-α|IL-1β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6860-47-5
-
Formula Weight282.24
-
Molecular FormulaC10H18O9?
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 250 mg/mL (885.77 mM)
-
SMILESO[C@@H]1CO[C@@H](O[C@@H]2COC(O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
-
Chemical NameD-Xylose 4-O-beta-D-xylopyranosyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Soo-Min L Eunju K Jae-Ho S et al. Xylobiose Prevents High-Fat Diet Induced Mice Obesity by Suppressing Mesenteric Fat Deposition and Metabolic Dysregulation[J]. Molecules 2018 23(3):705-.
molnova catalog
related products
-
GSK963 (Racemate)
GSK963 (Racemate) a structurally distinct potent and selective inhibitor of RIP1 kinase(IC50=29?nM).
-
Bergamotine
Bergamotine can significantly reduce blood glucose and increase glucose tolerance and insulin sensitivity in diabetic mice.
-
Pomalidomide
A potent inhibitor of TNF-α production; inhibits LPS-induced TNF-α release with IC50 of 13 nM in PBMCs.
